Heart Disease Trial, Recruiting (NCT07252830)

Heart Disease Trial, Recruiting NCT07252830 Sponsor: Elsan Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07252830 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 41 and 79 years old and have been referred to a general heart specialist (cardiologist)
People whose LDL cholesterol (often called "bad cholesterol") level is above 1.6 g/L, or above 1.3 g/L if they also have at least one major heart risk factor such as smoking, high blood pressure, or diabetes
People who have had two specific heart-related assessments — a coronary artery reserve assessment and a test called EDTSA — carried out during a day hospital visit

Who may not be able to join:

People who have been diagnosed with, or are suspected of having, a narrowing or build-up of fatty deposits in the arteries of the neck (carotid arteries)
People who have been diagnosed with, or are suspected of having, a significant blockage or reduced blood flow to the heart at the time of their first consultation
People who are under a legal protection arrangement, such as guardianship or curatorship, or whose freedom has been restricted by a court or administrative decision
People who have said they do not want their health information to be used in this study
People who may have difficulty understanding the information provided about the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07252830

Sponsor: Elsan

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

More information: https://clinicaltrials.gov/study/NCT07252830

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 41 and 79 years old and have been referred to a general heart specialist (cardiologist)
People whose LDL cholesterol (often called "bad cholesterol") level is above 1.6 g/L, or above 1.3 g/L if they also have at least one major heart risk factor such as smoking, high blood pressure, or diabetes
People who have had two specific heart-related assessments — a coronary artery reserve assessment and a test called EDTSA — carried out during a day hospital visit

Who may not be able to join:

People who have been diagnosed with, or are suspected of having, a narrowing or build-up of fatty deposits in the arteries of the neck (carotid arteries)
People who have been diagnosed with, or are suspected of having, a significant blockage or reduced blood flow to the heart at the time of their first consultation
People who are under a legal protection arrangement, such as guardianship or curatorship, or whose freedom has been restricted by a court or administrative decision
People who have said they do not want their health information to be used in this study
People who may have difficulty understanding the information provided about the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Elsan

Registry

ClinicalTrials.gov

Start date

12 September 2021

Est. completion

20 December 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Very high risk cardiovascular (yes/no)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov